Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-13-010330
Filing Date
2013-06-13
Accepted
2013-06-13 16:53:50
Documents
1
Period of Report
2013-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 4213
  Complete submission text file 0001179110-13-010330.txt   5586
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Issuer) CIK: 0001274792 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O METABOLIX 21 ERIE STREET CAMBRIDGE MA 02139
Business Address
Sinskey Anthony J (Reporting) CIK: 0001368753 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35409 | Film No.: 13911968